UnitedHealth Group Incorporated

UNH
$395.62 (- $6.11 - 1.52%)
Last updated: 2026-08-18 03:27 UTC
UNH Metrics
Exchange
🇺🇸 NYSE XNYS
New York Stock Exchange, Inc.United StatesAmerica/New_York
SectorHealthcare
IndustryHealthcare Plans
ISINUS91324P1021
CUSIP91324P102
Market Price395.62
Dividend Yield 2.35%
Dividend Growth
1Y +5.17%
3Y +11.81%
5Y +14.59%
10Y +22.76%
Annual Dividend 8.95
Latest Payout ($)2.32
Latest Payout Date2026-06-23
Dividend FrequencyQuarterly
P/E Ratio30.12
EPS19.22
Market Cap$322.7B
Book Value105.72
Price to Book3.139
Beta-0.39
52w High404.15
52w Low234.6
Next Earnings DateN/A

UnitedHealth Group Incorporated trades under ticker UNH on NYSE as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US91324P1021, CUSIP 91324P102. Also searched as UnitedHealth Group.

Related researchUNH stock priceUNH share priceUNH dividend historyUNH dividend yieldUnitedHealth Group dividend historyUnitedHealth Group dividend yield91324P102UnitedHealth Group stockUnitedHealth Group share price
About the Company
UnitedHealth Group Incorporated is a diversified health care company that provides health benefit plans, medical services, pharmacy care, and health technology solutions. Through UnitedHealthcare, it offers coverage for individuals, employers, Medicare and Medicaid beneficiaries, supporting access to care through broad provider networks and member services. Its Optum businesses deliver care delivery, pharmacy benefit management, data analytics, consulting, and software tools that support hospitals, physicians, payers, and public-sector clients. The company serves consumers, health care professionals, employers, and government organizations across the United States and internationally, making it a major participant in managed care and health services. UnitedHealth Group Incorporated plays a central role in connecting insurance, clinical care, and data-driven operations within the health care market.
Price History
Latest News for UNH
SCHD Just Made Big Changes. Is This Dividend Growth ETF Still a Buy?
The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) stands as one of the most popular dividend-growth vehicles on the market. Since its inception on October 20, 2011, the fund has delivered a cumulative total return of 478%, equating to a 13.3% annualized average. With a current yield of 3.3%, SCHD has turned a hypothetical $10,000 investment ... SCHD Just Made Big Changes. Is This Dividend Growth ETF Still a Buy?
Single Stocks Are Driving the Tape – Direxion Launches Four 2X Bull ETFs
2X Exposure to ADBE, PYPL, TXN, and UNH for Catalyst-Driven Trades Direxion.com Direxion.com New York, New York, March 25, 2026 (GLOBE NEWSWIRE) -- Direxion, a leading provider of Single Stock Leveraged & Inverse ETFs, today announced the launch of four new ETFs offering 2X daily exposure to Adobe Inc. (ADBE), PayPal Holdings Inc. (PYPL), Texas Instruments Inc. (TXN) and UnitedHealth Group Inc. (UNH). As trading activity increasingly centers on company-specific catalysts – from earnings and guid
UnitedHealth Faces Sole Antitrust Spotlight As Valuation Gap Widens
CVS Health has reached a proposed settlement with the Federal Trade Commission in a major antitrust case focused on pharmacy benefit managers. The settlement leaves UnitedHealth Group (NYSE:UNH) as the sole remaining defendant in the U.S. government’s ongoing lawsuit. This shift increases regulatory focus on UnitedHealth Group’s pharmacy benefit manager operations and its role in the broader case. UnitedHealth Group, trading at $272.28, now faces concentrated attention in a high profile...
CVS, FTC reach proposed settlement in insulin pricing case
A settlement between CVS' pharmacy benefit manager and antitrust regulators would leave UnitedHealth as the sole holdout in high-profile suit.
Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?
According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Andrew Harris Joins Red Sky Health as Senior Vice President of Operations
Red Sky Health, providers of an AI-driven platform that delivers healthcare claim denials remediation, today announced that recognized healthcare analytics leader, Andrew Harris, has joined the company as Senior Vice President of Operations. In this role, Harris will be responsible for scaling delivery, sharpening execution, and ensuring Red Sky Health continues to bring measurable, repeatable impact to every provider and partner they serve. Using advanced proprietary AI models trained on large